Artificial leaves could be drug factories

With photosynthesis, plants use sunlight to produce their own food. Dutch scientists have harnessed this type of approach to create an artificial leaf that uses a type of photosynthesis to create drugs wherever the sun shines.

The leaf acts as a mini factory by taking solar radiation and creates medicine through a luminescent solar concentrator.

"Theoretically, you could use this device to make drug compounds with solar energy anywhere you want," said lead researcher Timothy Noel at Eindhoven University of Technology in the Netherlands.

Read the full story by clicking the link below: 

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.